Mayne Pharma Group Ltd. has released a press release.
Mayne Pharma reports unaudited Q4 and FY26 results
Earlier from Mayne Pharma
- Mayne Pharma receives $14.4m for legal costs from Cosette
- Court awards MYX $13.27m for legal costs from Cosette
- Mayne Pharma reports unaudited 3Q FY26 results
- S&P DJI Announces March 2026 Quarterly Rebalance